QuiVad

Home / Netherlands / Lakefront Biotherapeutics NV

Lakefront Biotherapeutics NV

No short position is open on this share today.

Follow

Evolution of the disclosed total

0%1%2%3%
Oct 2025Jan 2026Apr 2026Jul 2026
Sum of open short positions, asĀ % of capital. Hover or tap the curve to see which funds make it up.
The whole history, peaking at 5.00% on May 21, 2018. The shaded band is the year shown above.

July 31, 2015 today

Open positions

No fund discloses a short position on this share today. The history below keeps the trace of the ones that existed.

Follow by RSS

Get the moves on Lakefront Biotherapeutics NV by mail.

No account: one address, one link to confirm, one link to stop in every message.

History of disclosures

689 disclosures on record for this share.
DateFund% of capitalEnd of publication
April 2, 2026Arrowstreet Capital, Limited Partnership0.48%
March 30, 2026Arrowstreet Capital, Limited Partnership0.58%
March 24, 2026Arrowstreet Capital, Limited Partnership0.69%
March 13, 2026Arrowstreet Capital, Limited Partnership0.77%
March 6, 2026Arrowstreet Capital, Limited Partnership0.89%
March 2, 2026Arrowstreet Capital, Limited Partnership0.98%
February 26, 2026Arrowstreet Capital, Limited Partnership1.05%
February 4, 2026Arrowstreet Capital, Limited Partnership1.19%
January 21, 2026Arrowstreet Capital, Limited Partnership1.29%
January 15, 2026Arrowstreet Capital, Limited Partnership1.38%
January 7, 2026Arrowstreet Capital, Limited Partnership1.49%
December 22, 2025Qube Research & Technologies Ltd.0.49%
December 18, 2025Qube Research & Technologies Ltd.0.50%
December 11, 2025Qube Research & Technologies Ltd.0.49%
October 24, 2025Qube Research & Technologies Ltd.0.59%
October 21, 2025Qube Research & Technologies Ltd.0.60%
October 15, 2025Arrowstreet Capital, Limited Partnership1.59%
August 26, 2025Millennium International Management LP0.29%
August 25, 2025Qube Research & Technologies Ltd.0.59%
August 22, 2025Millennium International Management LP0.50%
August 19, 2025Arrowstreet Capital, Limited Partnership1.69%
July 31, 2025Arrowstreet Capital, Limited Partnership1.79%
July 24, 2025Qube Research & Technologies Ltd.0.67%
July 17, 2025Citadel Advisors LLC0.48%
July 15, 2025Qube Research & Technologies Ltd.0.57%
July 9, 2025Citadel Advisors LLC0.58%
July 2, 2025Arrowstreet Capital, Limited Partnership1.80%
June 20, 2025Arrowstreet Capital, Limited Partnership1.71%
June 6, 2025Citadel Advisors LLC0.69%
May 28, 2025Arrowstreet Capital, Limited Partnership1.60%
May 22, 2025Citadel Advisors LLC0.71%
May 20, 2025Citadel Advisors LLC0.66%
May 20, 2025Qube Research & Technologies Ltd.0.61%
May 19, 2025Arrowstreet Capital, Limited Partnership1.53%
May 15, 2025Arrowstreet Capital, Limited Partnership1.43%
May 13, 2025Citadel Advisors LLC0.72%
May 9, 2025Arrowstreet Capital, Limited Partnership1.31%
May 7, 2025Citadel Advisors LLC0.67%
May 6, 2025Arrowstreet Capital, Limited Partnership1.20%
May 6, 2025Citadel Advisors LLC0.70%
April 30, 2025Arrowstreet Capital, Limited Partnership1.13%
April 25, 2025Qube Research & Technologies Ltd.0.51%
April 23, 2025Arrowstreet Capital, Limited Partnership1.01%
April 15, 2025Citadel Advisors LLC0.64%
April 14, 2025Citadel Advisors LLC0.58%
April 14, 2025Marshall Wace LLP0.49%
April 14, 2025Qube Research & Technologies Ltd.0.48%
April 7, 2025Qube Research & Technologies Ltd.0.50%
April 4, 2025Arrowstreet Capital, Limited Partnership0.90%
April 3, 2025Citadel Advisors LLC0.60%

Download 689 filings as CSV Columns: Date, Fund, Market, Disclosed position, Unit, End date. The other formats

Other companies sold short in the Netherlands

Cite this page

The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.

QuiVad, Lakefront Biotherapeutics NV, source AFM, data as at April 2, 2026, https://www.quivad.com/action/lakefront-biotherapeutics-nv